Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Confirmatory Trial Early Planning Is Essential To Address Potential Problems

Executive Summary

Sponsors should develop a strategy to address potential challenges to completion of accelerated approval confirmatory studies in advance of conducting the trials, members of FDA's Oncologic Drugs Advisory Committee suggested Nov. 8

You may also be interested in...



Pfizer Pulls Celebrex's FAP Indication Quickly After Slow Trial Results

The European Medicines Agency issues a formal review, even though the claim had been withdrawn, in order to discourage off-label use.

FDA Will Make Advisory Committee Review Of Accelerated Approvals An Annual Event

FDA plans to hold a yearly session with its Oncology Drugs Advisory Committee on cancer drugs granted accelerated approval as a means of holding sponsors' feet to the fire with regard to conducting confirmatory trials.

FDA Will Make Advisory Committee Review Of Accelerated Approvals An Annual Event

FDA plans to hold a yearly session with its Oncology Drugs Advisory Committee on cancer drugs granted accelerated approval as a means of holding sponsors' feet to the fire with regard to conducting confirmatory trials.

Related Content

Topics

UsernamePublicRestriction

Register

PS046544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel